Skip to main content

BioMachines' New Proteomics Services Arm Will Use Nonlinear Dynamics' 2D-Analysis Tech

NEW YORK (GenomeWeb News) – BioMachines will use Nonlinear Dynamics’ 2D analysis technology to support its new protein analysis service, Nonlinear Dynamics said today.
BioMachines said that its newly created Applied Proteomics Services Division will use Nonlinear’s SameSpots 2D analysis technology.
“We implemented the SameSpots approach in our 2D image analysis workflow as we recognize the significant time savings it offers on what is a labor-intensive process,” BioMachines CEO Tom Larrichio said in a statement.
“Applying SameSpots to the aligned images vastly reduces, and even removes in some cases the need for post-analysis editing," he said.

Financial terms of the deal were not disclosed.

The Scan

Gap in COVAX Doses

BBC News reports that COVAX is experiencing a vaccine shortfall, as the Serum Institute of India has paused exports.

Sanofi, GSK Report Promising Results

The Wall Street Journal reports that the candidate SARS-CoV-2 vaccine from Sanofi and GlaxoSmithKline has had encouraging early results.

Influence of Luck

The New York Times examines how the US avoided variant-fueled increases in COVID-19 cases.

PLOS Papers on Retina GWAS, Hantaan Virus, COVID-19 Phenome-Wide Association Study

In PLOS this week: genome-wide association study of retinal morphology, analysis of hantaan virus found in a mouse, and more.